Importance of translational research in the context of personalised cancer medicine

Speaker: Jordi Rodon

Jordi Rodon discusses the fundamentals in cancer biology and importance of integration of molecular oncology information generated in translational oncology studies, current use and limitations of molecular assays in oncology, complex regulatory environment in biological sample collection, regulatory requirements in performing and reporting biomarker studies, challenges in data analysis of translational studies, and value of public databases in translational research.

Discussion Points

  1. What is the importance of molecular oncology information generated in translational oncology studies and how can this be used?
  2. Please can you outline the current use and limitations of molecular assays in oncology?
  3. Why is there such a complex regulatory environment in biological sample collection?
  4. Why is it important to coordinate the regulatory requirements of pharma and academia in term of performing and reporting biomarker studies?
  5. How can public databases enrich translational research in oncology?